Author name: jainhospitals

Blog, Cadeditors

Prof Dr Raj kamal Choudhry, Associate Editor, Diabetes Asia Journal

/

Professor of Internal Medicine & HOD, MD Email [email protected] JAWHAR LAL NEHRU MEDICAL COLLEGE Public Health Expert Experienced  Doctor with a demonstrated history of working in the medical practice industry. Skilled in Epidemiology, Reproductive Health, Global Health, Healthcare Management, and Healthcare. Strong healthcare services professional with a Doctor of Medicine (M.D.) focused in Medicine from Rajendra Medical College, Ranchi. Has Experience working at the WHO as SRTL in India & Nigeria from 2002 to 2010. Worked as CDC Consultant in Polio and other VPD from 2011 to 2012. Teaching Faculty Professor in Postgraduate Medicine Department, Jawhar Lal Nehru Medical College, Bhagalpur, India  Hundreds of Scientific Research Papers in Various International and National Journals of Repute, including PubMed, Open Access, Medline, JAPI, and IJSR Life Member of API and CCDSI. Experienced Doctor with a demonstrated history of working in the medical practice industry. Skilled in Epidemiology, Reproductive Health, Global Health, Healthcare Management, and Healthcare. Strong healthcare services professional with a Doctor of Medicine (M.D.) focused in Medicine from Rajendra Medical College Ranchi.  Has Experience working at WHO as SRTL in India & Nigeria from 2002 to 2010. Worked as a CDC Consultant in Polio and other VPD from 2011 to 2012. Teaching Faculty Professor in Postgraduate Medicine Department, Jawahar Lal Nehru Medical College, Bhagalpur, India  Hundreds of Scientific Research Papers in Various International and National Journals of Repute, including PubMed, Open Access, Medline, JAPI, and IJSR Life Member of API and CCDSI.

Blog, Vol 2 Issue 4

The effect of dried camel milk on Type 1 Diabetes on Insulin Therapy

/

The effect of dried camel milk on Type 1 Diabetes on Insulin Therapy T. Mohammadabadi1, S. Verma2, P. Taneja3, A. Pratap4.1Agricultural Sciences and Natural Resources University, Faculty of Animal Science and Food Technology, Iran.2,3 GSVM Medical College, Obstetrics and Gynecology, Kanpur, India. 4SRTR Medical college, community medicine, Ambajogai, India. Submitted: 10 Dec 2025; Accepted: 25 Dec 2025; Published: 29 Dec 2025 Background Traditionally, in Africa, Asia, and the Middle East, camel milk is consumed regularly to manage diabetes, and drinking it lowers the incidence of diabetes. Since fresh camel milk is not available to all people globally, this study aimed to evaluate the antidiabetic effects of camel milk powder in diabetic patients. Camel milk has immune-stimulatory properties on the beta-cells of the pancreas, enhanced secretion of insulin, and decreased insulin resistance in diabetic subjects[1] Aim Evaluation of Camel milk in Type 1 Diabetes Blood parameters prospective study Methods: In this trial, 6 type 1 diabetic cases, who were on insulin for last few years were selected and given  15-gram camel milk powder /day which is equivalent to about 500 mL camel milk  and started for 3 months, two times daily in divided doses. Patients were not on any other medications except insulin or dietary regimens or exercises at least one month before the trial. Results The results showed a significant decrease in fasting and postprandial blood Glucose in patients fed camel milk powder, from 113 to 98 mg/dL (P = 0.001) and from 142 to 131 mg/dL (P = 0.02), respectively, after 3 months of taking camel milk powder. The LDL decreased significantly from 95 to 73 mg/dL(P0.02). Thus, camel milk powder may exhibit antidiabetic activity in patients with diabetes and improve cardiovascular health and other complications. The results also showed that the average required insulin dose before consuming camel milk powder was 42 ± 5 u/day, gradually decreasing to 30 ± 6 u/day (P = 0.02) three months after taking camel milk powder.

Blog, Vol 3 issue 1, Vol 3, Issue 1, April 2026

Short-term Studentship Project: KAP study on the Function of WHO

/

Short-term Studentship Project: KAP study on the Function of WHO Pauly1, Pawarsarvesh2, Prachi Gupta3, Prachi Jindal4, Pragya Singh51,2,3,4,5Batch 2022 MBBS Students, Department of Community Medicine, Rama Medical College Hospital & Research Center Corresponding author: Pauly – [email protected] Pragya singh – [email protected] Sarvesh Pawar- [email protected] Prachi Gupta, 4. Prachi Jindal – [email protected]

Vol 3, Issue 1, April 2026, Vol 3 issue 1

Safety and Efficacy of different Classes of Insulin as Add on Therapy of oral hypoglycemic agents in uncontrolled Type 2 Diabetes

/

Safety and Efficacy of different Classes of Insulin as Add on Therapy of oral hypoglycemic agents in uncontrolled Type 2 Diabetes Ashritha Kudikala1, Haripriya Kanaparthi, Mahibul Islam1, Satish Chinnala2 Abstract Aim: This study aims to evaluate the safety and efficacy of insulin as an adjunct therapy to one or More oral hypoglycaemic agents in patients withuncontrolled type 2 diabetes (T2D).Objectives: Assess the impact of insulin therapy on achieving the target blood glucose and glycated hemoglobin (HbA1c) levels. Examine the long-term effects of combining insulin therapy with oral hypoglycaemic agents on cardiovascular outcomes and overall mortality. Evaluate patient adherence to insulin therapy, considering factors influencing compliance such as dosing regimen, injection technique, and lifestyle adjustments.Results: The study involved 350 patients (183 females and 167 males) receiving various diabetes treatments: 230 on oral hypoglycaemics, 23 oninsulin, and 68 on a combination of therapies. A significant HbA1c reduction from 7.71% to 5.33% was observed. Mean FBS, post-FBS, and PPBS were166.57, 172.86, and 248.57 mg/dL, indicating improved glycaemic control. Conclusion: This study highlights the need for improved strategies to enhance compliance and adherence to treatment, address social habits, andmanage weight effectively. By optimizing insulin therapy alongside oral hypoglycaemics, healthcare providers can significantly improve glycaemiccontrol and overall health outcomes in patients with uncontrolled T2D. Keywords: Type 2 diabetes, insulin, oral hypoglycaemic drugs, adherence.

Diabetes-asia-Journal
Blog, Vol 3 issue 1, Vol 3, Issue 1, April 2026

The effect of dried camel milk on Type 1 Diabetes on Insulin Therapy

/

The effect of dried camel milk on Type 1 Diabetes on Insulin Therapy T. Mohammadabadi1, R. Jain2, R. Shoghli3, S. Agarwal4, S. Tiwari4, S. Verma4, P. Taneja4, A. Pratap5.1Agricultural Sciences and Natural Resources University, Faculty of Animal Science and Food Technology, Iran.2Jain hospital & Research Centre Pvt Ltd, Medicine, Kanpur, India.3University of Helsinki, Medicine, Helsinki, Finland.4GSVM Medical College,    Obstetrics and Gynaecology, Kanpur, India.5SRTR Medical college, community medicine, Ambajogai, India Abstract Background Traditionally, in Africa, Asia, and the Middle East, camel milk is consumed regularly to manage diabetes, and drinking it lowers the incidence of diabetes. Since fresh camel milk is not available to all people globally, this study aimed to evaluate the antidiabetic effects of camel milk powder in diabetic patients. Camel milk has immune-stimulatory properties on the beta-cells of the pancreas, enhanced secretion of insulin, and decreased insulin resistance in diabetic subjects[1] Aim Evaluation of Camel milk in Type 1 Diabetes: Blood parameters prospective study Methods: In this trial, 6 type 1 diabetic cases who had been on insulin for the last few years were selected and given 15-gram camel milk powder/day, equivalent to about 500 mL of camel milk, twice daily in divided doses for 3 months. Patients were not on any other medications except insulin or dietary regimens or exercises at least one month before the trial. Results The results showed a significant decrease in fasting and postprandial blood Glucose in patients fed camel milk powder, from 113 to 98 mg/dL (P = 0.001) and from 142 to 131 mg/dL (P = 0.02), respectively, after 3 months of taking camel milk powder. The LDL decreased significantly from 95 to 73 mg/dL(P0.02). Thus, camel milk powder may exhibit antidiabetic activity in patients with diabetes and improve cardiovascular health and other complications. The results also showed that the average required insulin dose before consuming camel milk powder was 42 ± 5 u/day, gradually decreasing to 30 ± 6 u/day (P = 0.02) three months after taking camel milk powder.

Blog, Vol 3 issue 1, Vol 3, Issue 1, April 2026

Primary Neonatal Outcomes in metformin and MNT group in Early Trimester with Early Gestational Glucose Intolerance

/

Primary Neonatal Outcomes in the metformin and MNT group in Early Trimester with Early Gestational Glucose Intolerance S. Agarwal1, S. Tiwari1, S. Verma1, P. Taneja1, S. Veeraswamy2, R. Jain3, P. Saxena4, A. Chandrasekar5, B.Natarajan6.1GSVM Medical College, Obstetrics and Gynaecology, Kanpur, India. 2The MGR Tamilnadu Medical University, Obstetrics and Gynecology, Chennai, India. 3 Jain Hospital & Research Centre Pvt Ltd, Medicine, Kanpur, India. 4 LHMC Medical College, Obstetrics and Gynaecology, New Delhi, India. 5 Madha Medical College and Research Institute, Obstetrics & Gynaecology, Chennai, India.6 SRC Diabetes Centre-, Diabetes, Erode, India Abstract MethodA study included pregnant women at 8 to 10 weeks of gestation, divided into two groups based on their blood sugar levels of≥110 mg/dl. Those with high levels ≥110 mg/dl received two different interventions: Metformin-MNT and MNT only. Follow-up outcomes were done until delivery.ResultsPrimary Outcomes* The Adverse neonatal composite outcomes in the groups were 35 (37.6%) vs 55 (52.3), which were statistically significant (P = 0.038), but the Primary Maternal hypertension composite outcomes were not significant (9 (9.6%) vs 10 (10.7%), P = 0.80) (Table 1). IUD/Spontaneous abortion 8-28 Weeks and stillbirth are 20 (16) and 12(9.6) in the MNT Group compared to nil in the MNT-Metformin intervention group, which is highly significant.Conclusion: It’s important to keep maternal 2-hour postprandial blood glucose (PPBG) levels below 110 mg/dL in the 10th week of pregnancy to prevent fetal hyperinsulinemia and improve maternal-fetal health.

Blog, Vol 3 issue 1, Vol 3, Issue 1, April 2026

Early Management of Early Gestational Glucose Intolerance

/

Early Management of Early Gestational Glucose Intolerance V. Seshiah1, P. Saxena2, A. Chandersekhar3, N. Bhavatharini4, G. Lakshmi5, B. .Madhuri6, S. Agarwal7,, S. Tiwari7, S. Verma7, R. Jain8 . 1The Tamilnadu Dr. MGR. Medical University, Chennai, India; Medicine, Chennai, India.2 LHMC, Obstetrics and Gynecology, New Delhi, India.3  Madha Medical College and Research Institute, Obstetrics and Gynecology, Chennai, India.4 SRC Diabetes Centre, Diabetes, Erode, India.5Chennai, Obstetrics and Gynaecology, Chennai, India.. 6Diabetes in pregnancy study Group of India, Diabetes, Chennai, India.7GSVM Medical College, Obstetrics and Gynaecology, Kanpur, India.. 8Jain Hospital & Research Center Pvt Ltd, Medicine, Kanpur, India. 1The Tamilnadu Dr. MGR. Medical University, Chennai, India; Medicine, Chennai, India.2 LHMC, Obstetrics and Gynaecology, New Delhi, India.3  Madha Medical College and Research Institute, Obstetrics and Gynecology, Chennai, India.4 SRC Diabetes Centre, Diabetes, Erode, India.5Chennai, Obstetrics and Gynaecology, Chennai, India.. 6Diabetes in pregnancy study Group of India, Diabetes, Chennai, India.7GSVM Medical College, Obstetrics and Gynaecology, Kanpur, India.. 8Jain Hospital & Research Center Pvt Ltd, Medicine, Kanpur, India.

Blog, Vol 2 Issue 4

The Asian Mosaic: Integrating Cardiometabolic Control and Adherence as One Narrative of Wellbeing

/

The Asian Mosaic: Integrating Cardiometabolic Control and Adherence as One Narrative of Wellbeing Jose Donato Magno , Reinhold Kreutz , Aslam Amod , Atul Pathak , Chan Siew Pheng , Om Lakhani , Jeyakantha, Ratnasingam , Arindam Pande , Effarezan Abdul Rahman , Zaw Lynn Aung , Peter Ting , Fatima Jehangir , Habibie Arifianto , Nhat Giang M , Kang-Un Choi , Sirinart Sirinvaravong , Md. Farid Uddin, Thu Thi Hoai Nguyen, Nure Alam, Azani Mohamed Daud.The Asian Mosaic: Integrating Cardiometabolic Control and Adherence as OneNarrative of Wellbeing. Diabetes Asia Journal. 2026;2(4):45-56. https://doi.org/10.62996/daj.70052025

Blog, Vol 2 Issue 4

Screening of Diabetes Patterns among Patients of Rangpur Division

/

Screening of Diabetes Patterns among Patients of Rangpur Division Author: Moniruzzaman Monir1 , Raton Kumar Ray2 , Shovro Kumar Gosh3, Humayra Ahmed4 The increasing prevalence of diabetes and prediabetes in Bangladesh, particularly within urban centers such as Rangpur Division, reflects agrowing public health crisis that demands urgent intervention. Community-based screening programs are essential for early detection, especially given the high proportion of undiagnosed cases across the country. A recent study conducted in the Dhap area of Rangpur City Corporation screened 70 individuals using fasting blood glucose (FBG),postprandial blood glucose (PPBG), and HbA1c levels to classify glycemic status into normal,prediabetic, or diabetic categories based on standard diagnostic criteria[1]. The findings revealed that the highest prevalence of diabeteswas observed among individuals aged 40–49 and 50–59 years, indicating a trend toward earlier onset of type 2 diabetes mellitus (T2DM) compared to global patterns where peak incidence typically occurs at older ages.

READY TO INSPIRE, INNOVATE, AND INFLUENCE? SUBMIT YOUR WORK TODAY!

Submit Your Manuscript

SHARE WITH YOUR COLLEAGUES!

Scroll to Top